Bringing New Biotech Treatments to Market

Kristen Fortney, BioAge Labs
In conversation with: Toby Corey, Stanford University

BioAge Labs co-founder and CEO Kristen Fortney explains why her company chose to start with finding treatments for diseases that are familiar to regulatory systems and potential payers, while maintaining a broader long-term vision.